10 IRIC Investigators receive a grant from the Canadian Institutes of Health Research (CIHR)

The Canadian Institutes of Health Research (CIHR) recently presented the grants of its Project Grant Program. For the fall competition, 10 IRIC Investigators received the valued grants, a success rate…

Agreement reached between the Hebrew University of Jerusalem and the University of Montreal and new collaborations with IRIC

Tel Aviv, May 23, 2017 – As part of his mission to Israel, the Premier of Quebec announced today an agreement between the Hebrew University of Jerusalem and the University of Montreal. It includes the…

Three IRIC students honored at UdeM’s Faculty of Medecine’s Molecular Biology program’s Scientific Day

On May 12th, 50 IRIC students gathered with other students and researchers for the UdeM Faculty of Medecine Molecular Biology Program’s Scientific Day.

This event was an opportunity for Master’s and …

IRICoR: a unique model

For the annual edition of the Canadian Society for Pharmaceutical Sciences (CSPS) and the Canadian Chapter of the Controlled Release Society (CC-CRS) conferences, Mrs. Nadine Beauger, Chief Executive …

Today’s fundamental research, a reflection of tomorrow’s breakthroughs

When working in a fundamental research laboratory in a cancer research institute, it is not unusual to hear the same refrain from friends or family, spoken with just a hint of irony: “So…. find anythi…

The Oncopole announces the appointment of its Executive Director, Ms. Stéphanie Lord-Fontaine

Montréal, May 8, 2017- The Oncopole, a research, development and investment hub designed to accelerate the fight against cancer, announced today the appointment of Ms. Stéphanie Lord-Fontaine as Execu…

IRIC welcomes two Nobel Laureates

At the invitation of its Chief Executive Officer, Michel Bouvier, IRIC is proud to welcome two recipients of the Nobel Prize.

The Institute received a visit from Brian Kobilka on 26 April and wil…

The Canadian National Proteomics Network honors Dr. Pierre Thibault with the 2017 Tony Pawson Proteomics Award

Dr. Thibault is an internationally renowned leader in mass spectrometry-based proteomics. His research contributions have spanned the elucidation of major environmental toxins, to the deep analysis of…

Identification of a Key Factor Controlling the Production of Blood Cells

The team of Dr. Julie Lessard, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal and professor at the Department of Pathology and Cell …

Claude Perreault Receives the Prestigious Bernhard Cinader Award from the Canadian Society for Immunology (CSI)

It’s in Banff, Alberta, that Dr. Claude Perreault, haematologist and Principal Investigator at the Institute for Immunology and Cancer (IRIC) at the Université de Montréal, received the Bernhard Cinad…

ExCellThera, wins the first prize at the HealthKick Challenge, in Toronto

The Institute for Research in Immunology and Cancer — Commercialization of Research (IRICoR) is pleased to announce that its clinical-stage spin-off company, ExCellThera, won the $20,000 first prize i…

IRICoR and C3i Announce Partnership to Identify novel Tumor-Specific Antigens (TSAs)

Novel Approach to Identifying TSAs based on a unique mass spectrometry approach discovered at IRIC combined with expertise in genomic sequencing and clinical validation from C3i

New antithrombotic drug developed through a research partnership between IRIC and Bristol-Myers Squibb

An article describing the identification and development of a new molecule to treat thrombotic diseases via a partnership with Bristol-Myers Squibb (BMS) was published in the January 4 edition of the …

A new proteomics approach reveals the importance of SUMOylation and its role in protein degradation in PML nuclear bodies

SUMOylation of the proteasome on its outer surface (left) allows its association with PML nuclear bodies by promoting its connection with…

Oncopole: A research, development, and investment hub to accelerate the fight against cancer

A $15 million investment from Merck

Merck & Co., Inc., and the Fonds de recherche du Québec – Santé (FRQS) are proud to announce the creation of Oncopole: a research, development, and investment hub …

Michel Bouvier receives the Julius Axelrod Award for his contributions as a scientist and mentor

Professor Michel Bouvier, Chief Executive Officer of the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal (UdeM) and professor in the Department of Biochemistry and Mol…

IRIC expands its medicinal chemistry core facility and announces the launch of phase II clinical trials for a molecule jointly identified by IRIC and Bristol-Myers Squibb

Representatives from provincial and federal governments, IRIC, IRICoR, Bristol-Myers Squibb (BMS), and life sciences sector.

On…

New Drugs for Old Crabs

Originating from the Greek “karkinos”, which means crab, cancer, like its crustacean counterpart, …